Syncytin is involved in breast cancer-endothelial cell fusions

Cellular and Molecular Life Sciences

Volumn 63, Issue 16, 2006, Pages 1906-1911

  Bjerregaard, B ^a   Holck, S ^b   Christensen, I J ^b   Larsson, L I ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

ASCT 2; Breast cancer; Endothelial cell; Fusion; Syncytin

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ENVELOPE PROTEIN; PROTEIN ASCT 2; RECEPTOR PROTEIN; SYNCYTIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL FUSION; CONTROLLED STUDY; ENDOTHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; PLACENTA; PROTEIN EXPRESSION; RETROVIRUS; TROPHOBLAST;

AMINO ACID TRANSPORT SYSTEM ASC; BASE SEQUENCE; BREAST NEOPLASMS; CELL FUSION; CELL LINE, TUMOR; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FEMALE; GENE PRODUCTS, ENV; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UMBILICAL VEINS;

EID: 33747273608     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6201-9     Document Type: Article

References (28)

1. Witze, E. and Rothman, J. H. (2002) Cell fusion: an EFFicient sculptor. Curr. Biol. 12, R467-R469.
2. Blond, J. L, Lavillette, D., Cheynet, V., Bouton, O., Oriol, G., Chapel-Fernandes, S., Mandrand, B., Mallet, F. and Cosset, F. L. (2000) An envelope glycoprotein of the human endogenous retroviras HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74, 3321-3329.
3. Mi, S., Lee, X., Li, X., Veldman, G. M., Finnerty, H., Racie, L., LaVallie, E., Tang, X. Y., Edouard, P., Howes, S., Keith, J. C. Jr and McCoy, J. M. (2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403, 785-789.
4. Duelli, D. and Lazebnik, Y. (2003) Cell fusion: a hidden enemy? Cancer Cell 3, 445-448.
5. Mortensen, K., Lichtenberg, J., Thomsen, P. D. and Larsson, L.-I. (2004) Spontaneous fusion between cancer cells and endothelial cells. Cell. Mol. Life Sci. 61, 2125-2131.
6. Barski, G. and Cornefert, F. (1962) Characteristics of 'hybrid'-type clonal cell lines obtained from mixed cultures in vitro. J. Natl. Cancer Inst. 28, 801-821.
7. Busund, L. T. R., Killie, M. K., Bartnes, K., Olsen, R. and Seljelid, R. (2002) Spontaneous hybridization of macrophages and Meth A sarcoma cells. Int. J. Cancer 98, 573-581.
8. Miller, F. R., McInerney, D., Rogers, C. and Miller, B. E. (1988) Spontaneous fusion between metastatic mammary tumor subpopulations. J. Cell. Biochem. 36, 129-136.
9. Wakeling, W. F., Greetham, J. and Bennett, D. C. (1994) Efficient spontaneous fusion between some co-cultured cells, especially murine melanoma cells. Cell Biol. Int. 18, 207-210.
10. Fortuna, M. B., Dewey, M. J. and Furmanski, P. (1990) Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett. 55, 109-114.
11. Goldenberg, D. M., Pavia, R. A. and Tsao, M. C. (1974) In vivo hybridisation of human tumor and normal hamster cells. Nature 250, 649-651.
12. Larizza, L., Schirrmacher, V., Graf, L., Pfluger, E., Peres-Martinez, M. and Stohr, M. (1984) Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int. J. Cancer 34, 699-702.
13. Munzarova, M., Lauerova, L. and Capkova, J. (1992) Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res. 2, 127-129.
14. Harris, H., Miller, O. J., Klein, G., Worst, P. and Tachibana, T. (1969) Suppression of malignancy by cell fusion. Nature 223, 363-368.
15. Harris, H. (1988) The analysis of malignancy by cell fusion: the position in 1988. Cancer Res. 48, 3302-3306.
16. Stanbridge, E. J. (1976) Suppression of malignancy in human cells. Nature 260, 17-20.
17. Wiener, F., Klein, G. and Harris, H. (1974) The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy. J. Cell Sci. 15, 177-183.
18. Anderson, M. J. and Stanbridge, E. J. (1993) Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J. 7, 826-833.
19. Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
20. Friedl, P. (2005) New mechanisms of plasticity in cancer? Lancet Oncology 6, 916-918.
21. Pawelek, J. M. (2005) Tumor-cell fusion as a source of myeloid traits in cancer. Lancet Oncol. 6, 988-993.
22. Duelli, D. M., Hearn, S., Myers, M. P. and Lazebnik, Y. (2005) A primate virus generates transformed human cells by fusion. J. Cell Biol. 171, 493-503.
23. Mortensen, K., Skouv, J., Hougaard, D. M. and Larsson, L.-I. (1999) Endogenous endothelial cell nitric oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J. Biol. Chem. 274, 37679-37684.
24. Frendo, J. L., Olivier, D., Cheynet, V., Blond, J. L., Bouton, O., Vidaud, M., Rabreau, M., Evain-Brion, D. and Mallet, F. (2003) Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol. Cell. Biol. 23, 3566-3574.
25. Chang C., Chen P. T., Chang G. D., Huang C. J. and Chen H. (2004) Functional characterization of the placental fusogenic membrane protein syncytin. Biol. Reprod. 71, 1956-1962.
26. Larsson, L.-I. (2004) Novel actions of tyrphostin AG 879: inhibition of RAF-1 and HER-2 expression combined with strong antitumor effects on breast cancer cells. Cell. Mol. Life Sci. 61, 2624-2631.
27. Smallwood, A., Papageorghiou, A., Nicolaides, K., Alley, M. K., Jim, A., Nargund, G., Ojha, K., Campbell, S. and Banerjee, S. (2003) Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10 and SGCE in human placenta. Biol. Reprod. 69, 286-293.
28. Antony, J. M., van Marle, G., Opii, W., Butterfield, D. A., Mallet, F., Yong, V. W., Wallace, J. L., Deacon, R. M., Warren, K., Power, C. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nature Neurosci. 7, 1088-1095.